Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema

Retina

Volumn 31, Issue 10, 2011, Pages 2102-2108

  Noma, Hidetaka ^a   Funatsu, Hideharu ^a   Mimura, Tatsuya ^b   Harino, Seiyo ^c   Shimada, Katsunori ^d  

^a Tokyo Women s Medical University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Branch retinal vein occlusion; Macular edema; Retinal sensitivity; Retinal thickness; Retinal volume

Indexed keywords

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA DETACHMENT; RETINA FOVEA; RETINA MACULA EDEMA; VISUAL ACUITY;

AGED; BLOOD PRESSURE; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MACULAR EDEMA; MALE; RETINA; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 80055094760     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318212e24d     Document Type: Article

References (23)

1. Michels RG, Gass JD. The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974;78: 166-177.
2. Gutman FA, Zegarra H. The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974;78:178-192.
3. Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007;143:601-606.
4. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425. (Pubitemid 46624280)
5. Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 2008;16:791-799. (Pubitemid 351426182)
6. Lee H, Shah GK. Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 2005;25:551-555. (Pubitemid 41077255)
7. Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-1128.
8. Suzuma K, Kita M, Yamana T, et al. Quantitative assessment of macular edema with retinal vein occlusion. Am J Ophthalmol 1998;126:409-416. (Pubitemid 28422066)
9. Lerche RC, Schaudig U, Scholz F, Walter A, Richard G. Structural changes of the retina in retinal vein occlusion-imaging and quantification with optical coherence tomography. Ophthalmic Surg Lasers 2001;32:272-280.
10. Imasawa M, Iijima H, Morimoto T. Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion. Am J Ophthalmol 2001;131:55-60. (Pubitemid 32037009)
11. Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N. Perimetric sensitivity with the microperimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol 2007;143:342-344. (Pubitemid 46136154)
12. Yamaike N, Tsujikawa A, Sakamoto A, et al. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 2009;29:757-767.
13. Kirchhoff AC, Drum ML, Zhang JX, et al. Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag 2008;15:125-131. (Pubitemid 351441218)
14. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005;140:256-261.
15. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006;244: 309-315.
16. Noma H, Funatsu H, Yamasaki M, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008; 22:42-48.
17. Barbazetto IA, Schmidt-Erfurth UM. Evaluation of functional defects in branch retinal vein occlusion before and after laser treatment with scanning laser perimetry. Ophthalmology 2000; 107:1089-1098.
18. Ota M, Tsujikawa A, Murakami T, et al. Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2008; 145:273-280.
19. Pavlidis M, Stupp T, Hummeke M, Thanos S. Morphometric examination of human and monkey retinal ganglion cells within the papillomacular area. Retina 2006;26:445-453. (Pubitemid 44201991)
20. Battaglia Parodi M, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999;237:1024-1027. (Pubitemid 30021293)
21. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139: 972-982.
22. Wroblewski JJ, Wells JA 3rd, Gonzales CR. Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion. Am J Ophthalmol 2010;149:147-154.
23. Kriechbaum K, Prager F, Geitzenauer W, et al. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Ophthalmology 2009;116:2415-2421.